IP Library Patent Application 14597466
Patent Application
App. No. 14/597,466

OXYGEN-RESPONSIVE BACTERIAL GENE SWITCH

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/597,466
Abstract

The invention provided herein relates to sequence determinants that elicit certain levels of gene expression and methods for obtaining engineered ligand-responsive gene switches comprising these sequence determinants. More particularly, the invention provided herein relates to molecular building blocks (i.e., discrete nucleotide sequences), synthetic ligand-responsive gene switches comprising an assembly of these molecular building blocks, and methods of using synthetic ligand-responsive gene switches as customizable and controllable expression systems and sensors.

Claims (13)

1 . A vector comprising a polynucleotide and a backbone not natively linked to the polynucleotide, the polynucleotide having a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1-32.

2 . The vector of claim 1 , wherein the polynucleotide is operably linked to a promoter.

3 . A bacterial host cell comprising the vector of claim 2 .

4 . The bacterial host cell of claim 3 , wherein the cell is an E. coli cell.

5 . An expression vector comprising a gene switch operably linked to a non-natively linked target nucleic acid sequence, the gene switch comprising one or more nucleic acid sequences having the sequence of a binding site of a transcriptional activator or transcriptional repressor, the gene switch configured to positively or negatively modify a gene expression level from the target nucleic acid sequence in a host cell comprising the expression vector when the cell is subjected to a change in oxygen concentration.

6 . The expression vector of claim 5 , wherein the one or more gene switch nucleic acid sequences are selected from the group consisting of SEQ ID NOs:1-32.

7 . The expression vector of claim 5 , wherein the gene switch comprises 1, 2, 3, 4, or 5 repeats of a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1-32.

8 . A method for modifying a level of gene expression of a target nucleic acid sequence, the method comprising:

introducing into a host cell an expression vector of claim 5 ; and

subjecting the host cell to a change in oxygen concentration until the gene expression level of the target nucleic acid sequence is modified.

9 . The method of claim 8 , wherein the gene expression level is modified under anaerobic conditions.

10 . The method of claim 8 , wherein the gene switch comprises one or more nucleic acid sequences selected from the group consisting of SEQ ID NOs:1-32.

11 . The method of claim 8 , wherein the gene switch comprises 1, 2, 3, 4, or 5 repeats of a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1-32.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 8, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046101/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2016
From: KILEY, PATRICIA; PARK, DAN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 039100/0367 →